Skip to main content
TipRanks
Go Ultimate75% OFF

We&Win Diversification Co., Ltd. (4113) AI Stock Analysis

TW:4113

We&Win Diversification Co., Ltd.

(TPEx:4113)

Select Model
Rating:37Underperform
Price Target:TWD 12.00â–¼(-7.34% Downside)
Action:initiatedcoverage
Date:11/09/26

The score is held down by weak financial fundamentals: a 67.5% revenue decline, a swing to a NT$100 million net loss, roughly NT$2.9 billion of cash burn, and rising leverage at about 2.3x debt-to-equity that leaves limited cushion between project delivery cycles. Technicals reinforce the caution, with the price below all key moving averages and negative MACD, though oversold RSI and Stochastic readings hint at scope for a near-term bounce. Valuation is mixed: the negative P/E provides no support, while a 6.6% dividend yield and low beta offer some appeal if the next project completions arrive on schedule. The business has shown it can deliver strong profits and cash in handover years, so the current weakness may be cyclical rather than structural, but visibility and financing risk keep the overall assessment low.

Positive Factors
Proven ProfitabilityThe company has demonstrated that its operations can generate healthy profitability when demand is supportive. This provides evidence of underlying earnings potential and a base for recovery if business volumes improve, although consistency remains unproven.
Negative Factors
Revenue VolatilityThe sharp reversal from revenue growth to a roughly 68% contraction shows that demand and operating performance are highly cyclical or unstable. Such volatility makes future earnings difficult to plan, weakens operating leverage, and raises the risk of prolonged underutilization.

We&Win Diversification Co., Ltd. (4113) vs. SPDR S&P 500 ETF (SPY)

-50%-40%-30%-20%-10%0%10%20%TW:4113-40.32%SPY+8.76%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 2.95B
Dividend Yield
6.56%
Average Volume (3M)
237.24K
Price to Earnings (P/E)
-14.8
Beta (1Y)
0.28
Revenue Growth
-90.66%
EPS Growth
-196.01%
Country
TW
Employees
35
Sector
General
Sector Strength
55
Industry
Engineering & Construction

We&Win Diversification Co., Ltd. Business Overview & Revenue Model

Company Description

We & Win Diversification Co., Ltd., a company headquartered in Kaohsiung City, Taiwan, primarily focuses on the acquisition, rental, and sale of real estate properties across the island. Beyond its core property activities, the firm's operations enco...

We&Win Diversification Co., Ltd. Financial Statement Overview

Summary

Financials are weak and highly cyclical. Revenue fell about 67.5% to roughly NT$610 million and the company swung from a NT$771 million profit to a NT$100 million loss, with return on equity near -2.3%. Leverage is aggressive, with debt-to-equity climbing to about 2.3x from 1.57x as borrowings rose nearly NT$2.6 billion to fund new projects while equity eroded. Cash flow is the weakest link: operating and free cash flow were roughly -NT$2.9 billion, the largest burn in six years, funded by debt. Offsetting positives include a steady ~19.5% gross margin, near-breakeven operating profit, minimal capital spending needs, and a demonstrated ability to produce large profits and NT$2.2 billion of operating cash in delivery years such as 2024.

Income Statement

29Negative

Balance Sheet

36Negative

Cash Flow

20Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue254.94M610.17M5.72B518.06M86.53M1.44B
Gross Profit55.77M119.09M1.52B109.23M27.40M364.49M
EBITDA-67.24M3.55M1.06B-40.27M-63.54M209.24M
Net Income-208.23M-100.03M770.81M-145.73M-144.21M133.65M
Balance Sheet
Total Assets16.60B15.84B13.20B15.34B14.04B12.60B
Cash, Cash Equivalents and Short-Term Investments312.50M420.36M1.34B221.49M854.70M1.16B
Total Debt10.15B9.74B7.10B9.35B8.47B7.03B
Total Liabilities12.42B11.58B8.68B12.23B10.78B9.12B
Stockholders Equity4.18B4.27B4.52B3.11B3.26B3.49B
Cash Flow
Free Cash Flow-1.08B-2.93B2.21B-970.67M-1.55B141.19M
Operating Cash Flow-1.07B-2.92B2.22B-937.22M-1.50B141.35M
Investing Cash Flow-56.04M-540.36M220.55M77.72M-70.79M-10.05M
Financing Cash Flow1.07B2.56B-1.60B869.59M1.31B245.04M

We&Win Diversification Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:4113 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:1752TW:175265NeutralTWD 3.01B14.70―5.37%-7.50%-23.52%
TW:1733TW:173363NeutralTWD 2.88B15.13―4.51%-8.15%17.27%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:6150TW:615048NeutralTWD 3.00B16.83―0.97%3.74%―
TW:6875TW:687537UnderperformTWD 3.27B-9.27――-69.26%-24.53%
TW:4113TW:411337UnderperformTWD 2.99B-14.78―6.56%-90.66%-196.01%

* General Sector Average

Performance Comparison

-40%-20%0%TW:4113TW:1733TW:1752TW:6150TW:6838TW:6875Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:4113 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:4113We&Win Diversification Co., Ltd.12.95-8.95-40.87%
TW:1733Apex Biotechnology Corp.28.85-2.52-8.04%
TW:1752Nang Kuang Pharmaceutical Co., Ltd.29.80-6.94-18.89%
TW:6150Tul Corporation62.00-9.80-13.65%
TW:6838Formosa Pharmaceuticals, Inc.21.00-6.30-23.08%
TW:6875Pharmosa Biopharm Inc.25.30-24.70-49.40%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026